CHU de Strasbourg

Strasbourg 67098

0 studies enrolling now · 5 studies all time

What they study most

Advanced Cancer, Bladder Cancer, COPD, Multiple Sclerosis, Relapsing-Remitting, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Relapsed or Refractory Follicular Lymphoma, Solid Tumor, Urothelial Carcinoma

Studies at this site

• A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma — Running, not enrolling
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• Evaluation of the Safety and Efficacy of TLD in Patients with COPD — Running, not enrolling
• Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) — Completed
• Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia — Stopped early